{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:26:04Z","timestamp":1791321964326,"version":"4.3.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.contraception.2007.11.014","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T15:57:31Z","timestamp":1201190251000},"page":"186-190","source":"Crossref","is-referenced-by-count":59,"title":["Ovulation inhibition by estetrol in an in vivo model"],"prefix":"10.1016","volume":"77","author":[{"given":"Herjan J.T.","family":"Coelingh Bennink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Skouby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F.","family":"Holinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2007.11.014_bib1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ajog.2006.12.015","article-title":"Oral contraceptive discontinuation: do side effects matter?","volume":"196","author":"Westhoff","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.11.014_bib2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.313.7065.1127","article-title":"Factor V Leiden: should we screen oral contraceptive users and pregnant women?","volume":"313","author":"Vandenbroucke","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2007.11.014_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejogrb.2004.11.023","article-title":"Risk of venous thromboembolic disease in women: a qualitative systematic review","volume":"121","author":"Romero","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2007.11.014_bib4","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2007.11.014_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0889-8553(05)70044-3","article-title":"Physical and metabolic factors in gallstone pathogenesis","volume":"28","author":"Donovan","year":"1999","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.contraception.2007.11.014_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jama.293.3.330","article-title":"Effect of estrogen therapy on gallbladder disease","volume":"293","author":"Cirillo","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2007.11.014_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/acta.0.0490207","article-title":"Metabolism of 17\u03b2-oestradiol-4-14C in early infancy","volume":"49","author":"Hagen","year":"1965","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.contraception.2007.11.014_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-4165(65)90464-2","article-title":"15a-hydroxylation: a new pathway of estrogen metabolism in the human fetus and newborn","volume":"100","author":"Schwers","year":"1965","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.contraception.2007.11.014_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1530\/acta.0.0500597","article-title":"Metabolism of oestrone sulphate by the previable human foetus","volume":"50","author":"Schwers","year":"1965","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.contraception.2007.11.014_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1530\/acta.0.0570208","article-title":"Studies on the metabolism of C-19 steroids in the human foeto-placental unit","volume":"57","author":"Mancuso","year":"1968","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.contraception.2007.11.014_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/13697130802040077","article-title":"Estetrol: a unique steroid in human pregnancy","author":"Holinka","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2007.11.014_bib12","article-title":"In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism","author":"Coelingh Bennink","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2007.11.014_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0022-4731(76)90184-9","article-title":"Competition of estetrol and ethynylestradiol with estradiol for nuclear binding in human endometrium","volume":"7","author":"Tseng","year":"1976","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2007.11.014_bib14","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0022-4731(78)90003-1","article-title":"Heterogeneity of saturable estradiol binding sites in nuclei of human endometrium; Estetrol studies","volume":"9","author":"Tseng","year":"1978","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2007.11.014_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0039-128X(76)90054-4","article-title":"Uterine estrogen receptor binding of catecholestrogens and of estetrol (1,3,5(10)-estratriene-3, 15a, 16a, 17b-tetrol)","volume":"27","author":"Martucci","year":"1976","journal-title":"Steroids"},{"key":"10.1016\/j.contraception.2007.11.014_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/biolreprod\/20.2.242","article-title":"In vivo effects of estetrol on the immature rat uterus","volume":"20","author":"Holinka","year":"1979","journal-title":"Biol Reprod"},{"key":"10.1016\/j.contraception.2007.11.014_bib17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1095\/biolreprod22.4.913","article-title":"Comparison of effects of estetrol and tamoxifen with those of estriol and estradiol on the immature rat uterus","volume":"22","author":"Holinka","year":"1980","journal-title":"Biol Reprod"},{"key":"10.1016\/j.contraception.2007.11.014_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1530\/acta.0.0980073","article-title":"Different effects of oestradiol, oestriol, oestetrol and of oestrone on human breast cancer cells (MCF-7) in long term tissue culture","volume":"98","author":"Jozan","year":"1981","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.contraception.2007.11.014_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-4731(71)90012-4","article-title":"Excretion of 15a-hydroxyestriol and estriol in maternal urine during normal pregnancy","volume":"2","author":"Heikkil\u00e4","year":"1971","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.contraception.2007.11.014_bib20","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/jcem-40-4-560","article-title":"Plasma estetrol as an index of fetal well-being","volume":"40","author":"Tulchinsky","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2007.11.014_bib21","first-page":"276","article-title":"Comparison of serum unconjugated estriol and estetrol in normal and complicated pregnancies","volume":"58","author":"Kundu","year":"1981","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.11.014_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/13697130701798692","article-title":"Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model","author":"Coelingh Bennink","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2007.11.014_bib23","first-page":"1010","article-title":"Endocrinological studies with (7\u03b1, 17\u03b1)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14)","volume":"34","author":"De Visser","year":"1984","journal-title":"Arzneim Forsch"},{"key":"10.1016\/j.contraception.2007.11.014_bib24","doi-asserted-by":"crossref","DOI":"10.1080\/13697130802056511","article-title":"First human exposure to exogenous oral estetrol in early postmenopausal women","author":"Visser","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2007.11.014_bib25","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/0002-9378(90)90550-Q","article-title":"Pharmacokinetics of ethinyl estradiol and mestranol","volume":"163","author":"Goldzieher","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.11.014_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2307\/2953417","article-title":"Oral contraceptive use and protective behavior after missed pills","volume":"29","author":"Oakley","year":"1997","journal-title":"Fam Plann Perspect"},{"key":"10.1016\/j.contraception.2007.11.014_bib27","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1016\/S0010-7824(98)00078-X","article-title":"Oral contraceptive estrogen dose considerations","volume":"58","author":"Kaunitz","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.11.014_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/13697130701842490","article-title":"Estrogenic uterogenital effects of oral estetrol in the rat","author":"Heegaard","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2007.11.014_bib29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1210\/jcem-31-4-436","article-title":"Fate of 15a-hydroxyestriol-3H in adult man","volume":"31","author":"Fishman","year":"1970","journal-title":"J Clin Endocrinol"},{"key":"10.1016\/j.contraception.2007.11.014_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/jcem-35-3-339","article-title":"Metabolism, production and excretion rates of 15a-hydroxyestriol in late pregnancy","volume":"35","author":"Fishman","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2007.11.014_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/13697130701822807","article-title":"Preventive effect of oral estetrol in a menopausal hot flush model","author":"Holinka","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2007.11.014_bib32","article-title":"Anti-estrogenic effects of oral estetrol in the DMBA breast cancer model","author":"Coelingh Bennink","year":"2008","journal-title":"Climacteric"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078240700515X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078240700515X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T05:40:35Z","timestamp":1557207635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078240700515X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S001078240700515X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2007.11.014","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}